Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.007 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |